- Cell Biology
- Product Type
- Research Area
- New Products
- About Tocris
- Contact Us
Monoacylglycerol lipase (MAGL, MGL) is a hydrolase that is involved in endocannabinoid and triglyceride hydrolysis. It is the primary enzyme responsible for the metabolism of 2-arachidonylglycerol (2-AG) in the brain, and is also involved in lipid signaling.
|Cat No||Product Name / Activity|
|Potent and selective MAGL inhibitor|
|Dual FAAH and MAGL inhibitor|
|Potent and selective reversible MAGL inhibitor|
|Highly potent and selective MAGL inhibitor|
|Potent, reversible MAGL inhibitor|
|Non-competitive MAGL inhibitor|
Monoacylglycerol lipase (MAGL, MGL) is a serine hydrolase that breaks down monoacylglycerols to glycerol and fatty acid. It is the primary enzyme responsible for the metabolism of 2-arachidonylglycerol (2-AG) in the brain, and is also involved in lipid signaling.
2-AG acts as an endocannabinoid - an endogenous agonist of GPR55, CB1 and CB2 receptors. MAGL hydrolyzes 2-AG, attenuating endocannabinoid signaling and also generating arachidonic acid, which can be used in the synthesis of pro-inflammatory eicosanoids such as PGE2. MAGL inhibitors can therefore exhibit both antinociceptive and anti-inflammatory effects.
2-AG is structurally similar to anandamide (AEA), but the latter is hydrolyzed by fatty acid amide hydrolase (FAAH). FAAH and MAGL co-localize with CB1 receptors in the hippocampus, cerebellum and amygdala, but are distributed in different areas of the synapse - FAAH is expressed postsynaptically, whilst MAGL is expressed in the presynaptic terminal. Both enzymes play an important role in retrograde endocannabinoid signaling, as 2-AG and AEA activate CB1 receptors expressed in the presynaptic terminal to inhibit neurotransmitter release. Hydrolysis of these endocannabinoids by FAAH and MAGL prevents persistent CB1 receptor activation and desensitization.
MAGL was initially discovered in the context of lipid signaling in adipocytes. The enzyme hormone sensitive lipase (HSL) hydrolyzes triacylglycerols to monoacylglycerols, which are in turn hydrolyzed by MAGL to release free fatty acids. This is the last step of hydrolysis in adipocytes, and provides fuel during periods of glucose deprivation. The free fatty acids released from monoacylglycerol hydrolysis may be used in the synthesis of prostaglandin E2 (PGE2) and lysophosphatidic acid (LPA), dysregulation of which has been linked to cancer. Recent research has shown that MAGL may control the generation of free fatty acids in cancer cells, enabling them to fuel tumor growth.
The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.
Peripheral sensitization is the reduction in the threshold of excitability of sensory neurons that results in an augmented response to a given external stimulus. This poster outlines the excitatory and inhibitory signaling pathways involved in modulation of peripheral sensitization. The role of ion channels, GPCRs, neurotrophins, and cytokines in sensory neurons are also described.